Despite early failures in the clinic, the idea of anti-aging therapies that purge the body of dying cells is gaining traction with a raft of startups now focused on senescence.
Valuable review describing the emerging field of therapeutic development targeting senescence biology to treat age-related conditions.
Join us at LT2021. Rubedo will be contributing with a lecture and a round table.
Rubedo Life Sciences CEO, Dr. Marco Quarta, will be Chairman of the Conference
on Day 1 – he will join the Panel Discussion titled
A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities
On Day 2 – Dr. Quarta will give a lecture on
Higher selectivity and safety of Targeted Senolytcs
Salaried internship opportunities at Rubedo Life Sciences for 2021-2022
9 month internship – CalPoly CIRM Master Program for Regenerative Medicine
Summer Internship – SENS Research Foundation Program
Rubedo Life Sciences presents results from its strategy of engineered small molecules to target senescence cells in chronic diseases at Ending Age-Related Diseases Conference